Rodman & Renshaw Maintains Market Outperform on Dendreon

Rodman & Renshaw is out with its report today on Dendreon

, maintaining Market Outperform. In its report, Rodman & Renshaw writes, "We are reiterating our Market Outperform rating for Dendreon and maintaining our price target of $17 based on a discounted 2015 EPS and revenues valuation analysis. The bottom-line is that significant uncertainty exists in the near-term." At the time of posting, shares of DNDN were trading at $11.09, up 1.93% from Thursday's close.